These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2699289)

  • 1. Cyclosporine pharmacokinetics and effect in the type I diabetic rat model.
    Brunner LJ; Iyer LV; Vadiei K; Weaver WV; Luke DR
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):287-92. PubMed ID: 2699289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cyclosporine in streptozotocin-induced diabetic rats.
    D'Souza MJ; Solomon HM; Fowler LC; Pollock SH
    Drug Metab Dispos; 1988; 16(5):778-80. PubMed ID: 2906606
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
    Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
    Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker rat.
    Berens KL; Vadiei K; Brunner LJ; Wasan KM; Luke DR
    Biopharm Drug Dispos; 1990 Apr; 11(3):197-206. PubMed ID: 2328306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues.
    Elçioğlu HK; Kabasakal L; Özkan N; Çelikel Ç; Ayanoğlu-Dülger G
    Eur J Pharmacol; 2011 Jun; 660(2-3):476-84. PubMed ID: 21463620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
    Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
    J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes.
    Lindsay RM; Jamieson NS; Walker SA; McGuigan CC; Smith W; Baird JD
    Diabetologia; 1998 May; 41(5):516-23. PubMed ID: 9628267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephro-protective effects of total triterpenoids from Psidium guajava leaves on type 2 diabetic rats].
    Kuang QT; Zhao JJ; Ye CL; Wang JR; Ye KH; Zhang XQ; Wang Y; Ye WC
    Zhong Yao Cai; 2012 Jan; 35(1):94-7. PubMed ID: 22734419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
    Adewole SO; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SMS 201-995 on the pharmacokinetic profile and cellular immune and toxic effects of cyclosporine in male Wistar rats.
    Yale JF; Ahmed S; Maharajh G
    Transplantation; 1991 Aug; 52(2):336-40. PubMed ID: 1871808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
    Hakim ZS; Goyal RK
    Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent pharmacokinetics and toxicity of cyclosporine.
    Luke DR; Vadiei K; Brunner LJ
    Chronobiol Int; 1988; 5(4):353-62. PubMed ID: 3069229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
    Ao Y; Chen J; Yue J; Peng RX
    Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of experimental diabetes mellitus on the pharmacokinetics of atenolol enantiomers in rats.
    Mehvar R
    J Pharm Sci; 1991 Mar; 80(3):207-11. PubMed ID: 2051334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent.
    Emami J; Gerstein HC; Pasutto FM; Jamali F
    Can J Physiol Pharmacol; 1999 Feb; 77(2):118-23. PubMed ID: 10535702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhein promotes the expression of SIRT1 in kidney tissues of type 2 diabetic rat].
    Chen W; Chang B; Zhang Y; Yang P; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):615-9. PubMed ID: 25940287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.